Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Serotonin syndrome after a massive overdose of controlled-release paroxetine.

Muzyk AJ, Jakel RJ, Preud'homme X.

Psychosomatics. 2010 Sep-Oct;51(5):437-42. doi: 10.1176/appi.psy.51.5.437.

PMID:
20833944
2.

Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury.

Satoh K, Takano S, Onogi T, Ohtsuki K, Kobayashi T.

Fukushima J Med Sci. 2006 Jun;52(1):29-33.

3.

[Possible serotoninergic syndrome associated with coadministration of paroxetine and tramadol].

Llinares-Tello F, Escrivá-Moscardó S, Martínez-Pastor F, Martínez-Mascaraque P.

Med Clin (Barc). 2007 Mar 24;128(11):438. Spanish. No abstract available.

PMID:
17394862
4.

[Serotonergic syndrome. Serotonergic syndrome caused by paroxetine].

Hilberg T, Mørland J.

Tidsskr Nor Laegeforen. 1999 Apr 30;119(11):1646-7. Norwegian. No abstract available.

PMID:
10385811
5.

Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine.

Murray KL, Miller KM, Pearson DL.

J Perinatol. 2007 Aug;27(8):517-8.

PMID:
17653218
6.

The serotonin syndrome complicating co-prescription of paroxetine and clarithromycin.

Jaber BL, Lobon LF, Madias NE.

Am J Med. 2006 Apr;119(4):e3. No abstract available.

PMID:
16564762
7.

Efficacy and tolerability of controlled-release paroxetine.

Golden RN.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:176-86. Review.

PMID:
14566210
8.

[Combination of serotonergic agents resulted in severe adverse effects].

Jägestedt M, von Bahr C.

Lakartidningen. 2004 Apr 29;101(18):1618-9. Swedish.

PMID:
15185539
9.

Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report.

Hanekamp BB, Zijlstra JG, Tulleken JE, Ligtenberg JJ, van der Werf TS, Hofstra LS.

Neth J Med. 2005 Sep;63(8):316-8.

10.

Efficacy of controlled-release paroxetine in the treatment of late-life depression.

Rapaport MH, Schneider LS, Dunner DL, Davies JT, Pitts CD.

J Clin Psychiatry. 2003 Sep;64(9):1065-74.

PMID:
14628982
11.

Pharmacokinetics, drug interactions, and tolerability of paroxetine and paroxetine CR.

DeVane CL.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:29-41. Review.

PMID:
14566199
12.

Paroxetine in the treatment of generalised anxiety disorder.

Snyderman SH, Rynn MA, Bellew K, Rickels K.

Expert Opin Pharmacother. 2004 Aug;5(8):1799-806. Review.

PMID:
15264994
13.

Serotonin syndrome with elevated paroxetine concentrations.

Velez LI, Shepherd G, Roth BA, Benitez FL.

Ann Pharmacother. 2004 Feb;38(2):269-72. Epub 2003 Dec 15.

PMID:
14742765
14.

Nocturnal enuresis after paroxetine abrupt discontinuation: a case report.

Polimeni G, Grugno R, Cordici F, Vitetta A, Caputi AP, Bramanti P.

J Clin Psychopharmacol. 2008 Oct;28(5):589-91. doi: 10.1097/JCP.0b013e3181850bc2. No abstract available.

PMID:
18794668
15.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
16.

Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial.

Rapaport MH, Lydiard RB, Pitts CD, Schaefer D, Bartolic EI, Iyengar M, Carfagno M, Lipschitz A.

J Clin Psychiatry. 2009 Jan;70(1):46-57. Epub 2008 Oct 7.

PMID:
19026248
17.

The serotonin syndrome scale: first results on validity.

Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenheil M, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 1998;248(2):96-103.

PMID:
9684919
18.

Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.

Weihs KL, Settle EC Jr, Batey SR, Houser TL, Donahue RM, Ascher JA.

J Clin Psychiatry. 2000 Mar;61(3):196-202.

PMID:
10817105
20.

History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.

Pae CU, Masand PS, Marks DM, Krulewicz S, Han C, Peindl K, Mannelli P, Patkar AA.

World J Biol Psychiatry. 2009;10(4 Pt 2):435-41. doi: 10.1080/15622970902789155.

PMID:
19382010
Items per page

Supplemental Content

Write to the Help Desk